Article

Umbilical hernia in a patient with cirrhosis

From Cleveland Clinic Journal of Medicine 2015 Jul;82(7):404-405. </br>Ascites is the major predisposing factor, since it causes muscle wasting and increases intra-abdominal pressure.

Author and Disclosure Information

 

References

A 62-YEAR-OLD MAN was admitted to the intensive care unit with esophageal variceal bleeding. He had a long history of alcohol abuse with secondary cirrhosis, with a Child-Pugh score of 11 on a scale of 15 (class C—the most severe) at presentation. He also had a history of uncomplicated umbilical hernia, 6 cm in diameter without overlying trophic skin alterations.

Treatment with somatostatin, endoscopic band ligation, and prophylactic antibiotics was initiated for the variceal bleeding. The next day, he was transferred to the hepatology floor. His condition stabilized during the next week, but then he abruptly became diaphoretic and less talkative. Physical examination revealed a painful and irreducible umbilical hernia (Figure 1). He was rushed for umbilical hernia repair with resection of a necrotic segment of small bowel. His recovery after surgery was uneventful, and he was eventually discharged.

UMBILICAL HERNIA AND CIRRHOSIS

Umbilical hernia is common in cirrhotic patients suffering from ascites, with a prevalence up to 20%, which is 10 times higher than in the general population.1 Ascites is the major predisposing factor since it causes muscle wasting and increases intra-abdominal pressure.

FIGURE 1. Incarcerated umbilical hernia in a 62-year-old patient with Child-Pugh class C cirrhosis.

A unique feature of cirrhosis is low physiologic reserve, which increases the risk of death from complications of umbilical hernia and makes the patient more vulnerable to perioperative complications during repair. Because of the high operative risk, umbilical hernia repair has traditionally been reserved for the most complicated cases, such as strangulation of the bowel or rupture of the skin with leakage of ascitic fluid.2,3 Many patients are thus managed conservatively, with watchful waiting.

However, the natural course of umbilical hernia tends toward complications (eg, bowel incarceration, rupture of the overlying skin), which necessitate urgent repair.4 The risk of death with hernia repair in this urgent setting is seven times higher than for elective hernia repair in cirrhotic patients.5 More recent data indicate that elective repair in patients with well-compensated cirrhosis carries complication and mortality rates similar to those in noncirrhotic patients.5–8 Therefore, patients who should undergo umbilical hernia repair are not only those with complicated umbilical hernia (strangulation or ascites leak), but also those with well-compensated cirrhosis at risk of complications.

Factors that pose a particularly high risk of complications of repair are large hernia (> 5 cm), hernia associated with pain, intermittent incarceration, and trophic alterations of the overlying skin.1 In these patients, elective repair should be considered if hepatic function is preserved, if ascites is well managed (sodium restriction, diuretics, and sometimes even preoperative transjugular intrahepatic portosystemic shunt placement), and if the patient is not expected to undergo liver transplantation in the near future. If liver transplantation is anticipated in the short term, umbilical hernia can be managed concomitantly. Management of ascites after umbilical hernia repair is essential for prevention of recurrence.

Recommended Reading

VIDEO: NAFLD increasingly causing U.S. hepatocellular carcinomas
MDedge Family Medicine
Catching up on the latest USPSTF recommendations
MDedge Family Medicine
Taking the mystery out of hepatitis C testing for patients
MDedge Family Medicine
Consider HCV ‘a cardiovascular risk factor’
MDedge Family Medicine
VIDEO: Stroop app predicts hepatic encephalopathy
MDedge Family Medicine
DDW: Gestational diabetes linked to increased NAFLD risk in middle age
MDedge Family Medicine
Cirrhosis complications: Keeping them under control
MDedge Family Medicine
Managing dyspepsia
MDedge Family Medicine
Helping patients afford the new hepatitis C medications
MDedge Family Medicine
VIDEO: Nivolumab puts brakes on advanced liver cancer
MDedge Family Medicine

Related Articles